Home » Topics » BioWorld Science

BioWorld Science
RSS

PharmEnable and Denali Therapeutics to collaborate in neurodegenerative disease research

May 31, 2022

New CD73 inhibitors patented by Humanwell Healthcare

May 31, 2022

Boehringer Ingelheim presents new indoleamine 2,3-dioxygenase 1 inhibitors

May 31, 2022

New menin/MLL interaction inhibitors synthesized at Shanghai Euregen Biopharma

May 31, 2022

Suzhou Yabao Pharmaceutical Research and Development patents mutant LRRK2 inhibitors

May 31, 2022

SLC13A5 inhibitors identified at the Rosalind Franklin University of Medicine and Science

May 31, 2022

Glycoengineering improves the anti-inflammatory effects of small extracellular vesicles

May 31, 2022

NRG Therapeutics receives Biomedical Catalyst award for neurodegenerative disorders

May 31, 2022

Discovery of novel orally bioavailable SERD with enhanced pharmacological properties

May 31, 2022

Novel tricyclic HIV-1 integrase-LEDGF/p75 allosteric inhibitors show improved antiviral activity

May 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...